References
- Moreillon P, Que YA, Glauser MP. Staphylococcus aureus (including staphylococcal toxic shock). In: Mandell GL, Bennett JE, Dolin R Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th edn. New York: Churchill Livingston; 2005. p. 2321–48.
- Donowitz GR. Oxazolidinones. In: Mandell GL, Bennett JE, Dolin R Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th edn. New York: Churchill Livingston; 2005. p. 436–40.
- Cedric J, Caillon J, Le Mabeque V, Miègeville AF, Donnio PV, Bugnon D, et al. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. J Antimicrob Chemother 2003; 51: 857–64
- Shaikh ZH, Peloquin CA, Ericsson CD. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 2001; 33: 375–9
- Villani P, Regazzi MB, Marubbi F, Viale P, Pagani L, Cristini F, et al. Cerebrospinal fluid linezolid concentrations in post-neurosurgical central nervous system infections. Antimicrob Agents Chemother 2002; 46: 936–7
- Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–51
- Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–75
- Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, et al. Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan. Int J Hematol 2007; 85: 238–41
- Fowler VG, Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163: 2066–72
- Matsubara H, Makimoto A, Higa T, Kawamoto H, Kanda Y, Kami M, et al. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient. Bone Marrow Transplant 2003; 31: 65–7
- Amod F, Moodley I, Peer AK, Sunderland J, Lovering A, Wootton M, et al. Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA):successful treatment with linezolid in combination with intraventricular vancomycin. J Infect 2005; 50: 252–7
- Pistella E, Campanile F, Bongiorno D, Stefani S, Di Nucci GD, Serra P, et al. Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid. Scand J Infect Dis 2004; 36: 222–5
- Viale P, Pagani L, Cristini F, Stefini R, Bergomi R, Colombini P, et al. Linezolid for the treatment of central nervous system infections in neurosurgical patients. Scand J Infect Dis 2002; 34: 456–9
- Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, et al. Endothelial damage caused by cytomegalovirus and human herpes virus-6. Bone Marrow Transplant 2003; 31: 475–9
- Kessler AT, Kourtis AP. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection 2007; 35: 271–4
- Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B, et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002; 46: 2723–6